Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using social media to find live organ donors for patients in need

Official title: Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

Run by Johns Hopkins University · NCT03803423 · Data updated 2026-11-12

This study is testing if using social media to share stories can help patients waiting for organ transplants find live donors more easily.

More End Stage Renal Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorJohns Hopkins University
Academic / other
Locations6 sites (San Diego, California and 5 other locations)
StatusRecruiting
StartedNovember 27, 2017
Main results expectedNovember 27, 2026
Study endsNovember 27, 2026
Registry record updatedNovember 10, 2025
Trial IDNCT03803423 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are on the kidney-only or liver-only transplant waiting list.

Probably not a fit

Patients who are younger than 18, not on the transplant waiting list, or on multiple organ transplant waiting lists may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to address the challenges faced by patients on the organ transplant waitlist in identifying potential live donors. By utilizing a web-based application called the 'Donor App', participants can share their stories on social media platforms to raise awareness about their need for a living donor. The approach focuses on overcoming barriers such as lack of education and reluctance to discuss live donation. The hypothesis is that increased visibility through social media will facilitate connections between transplant candidates and potential donors, ultimately improving the chances of finding a live donor.

Why it matters

Potential benefit: If successful, this approach could significantly increase the number of live organ donors available for patients with end-stage renal and liver diseases.

How similar studies have gone: While the use of social media in healthcare is gaining traction, this specific approach to identifying live organ donors through a dedicated application is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 18 years of age
* On the kidney-only or liver-only transplant waiting list at a collaborating center

Exclusion Criteria:

* Younger than 18 years of age
* Not on the kidney or liver transplant waiting list
* On multiple organ transplant waiting lists

Where it's running

  • The Johns Hopkins Hospital
    Baltimore, Maryland, United States
    Recruiting
  • Scripps Green Hospital
    San Diego, California, United States
    Enrolling by invitation
  • Yale University
    New Haven, Connecticut, United States
    Enrolling by invitation
  • Rush University Medical Center
    Chicago, Illinois, United States
    Not yet recruiting
  • Maine Medical Center
    Portland, Maine, United States
    Enrolling by invitation
  • Washington University in St. Louis
    St Louis, Missouri, United States
    Enrolling by invitation

Study contacts

  • Principal investigator: Andrew Cameron, MD PhD — Johns Hopkins University
  • Study coordinator: Andrew Cameron, MD PhD
  • Email: donorapp@jhu.edu
  • Phone: 4432870134

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Ribupatide PK in People with Kidney Impairment

    This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.

    Recruiting at 2 sites Phase 1 Kailera · Orlando, Florida and 1 other locations · NCT07793929

  • Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease

    This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.

    Recruiting Pardis Specialized Wellness Institute · Isfahan · NCT07720401

  • Pumpkin seed oil for people on hemodialysis

    This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.

    Recruiting Al-Mustansiriyah University · Baghdad, Karkh · NCT07710183

  • Porcine thymokidney transplant for end-stage renal disease

    This study tests whether a GalKO porcine thymokidney transplant can keep kidney function without dialysis in adults with end-stage kidney disease who are unlikely to get a standard donor kidney soon.

    Recruiting Phase 1 Xeno Holdings (US), LLC dba ChoironeX · New York, New York and 1 other locations · NCT07696962

  • Even protein distribution plus exercise for people awaiting liver transplant

    This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.

    Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07561138

  • Preoperative Carbohydrate Loading Before Liver Transplant

    This study tests whether drinking a carbohydrate beverage before anesthesia helps liver transplant patients recover faster.

    Recruiting Medical University of Warsaw · Warsaw · NCT07519057

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.